Respiratory distress syndrome is the second major cause of newborn mortality. Health care providers especially struggle to deliver oxygen to preterm newborns, who account for roughly one-tenth of all births in the U.S., because lungs are among the last organs to fully develop in the womb. A new microfluidics innovation shows hope to improve artificial placentas so preterm newborns can properly develop lungs following birth.